Chinese drug sector’s stature grows at major cancer conference
South China Morning Post
The brief
An array of Chinese drug makers showcased positive trial results for new cancer treatments at a major European medical conference, underscoring the expanding international influence of China’s biotech sector. Domestic innovative drugs, particularly antibody-drug conjugates (ADCs), delivered impressive data across multiple tumour types at the European Society for Medical Oncology (Esmo) Congress, with some early-stage…
Reported by
South China Morning Post
This is a short headline brief. The complete report belongs to its publisher.
